Xton Access Manager Product Update
Today we released our Xton Access Manager software. Release 2.3.201801072216 adds the following:
- An option to request approval for remote task execution
- An option to mass schedule on-demand execution of multiple tasks for several selected records and to request approval for executing remote scripts for multiple selected records as well
- An option for break-glass recovery of sensitive information from encrypted system export using administration utility
- An option to bulk copy, cut, paste and delete multiple selected records and folders
There are some other issues fixed and new functions implemented. See release notes for details:
The software requires about five minutes to install on a freshly built Windows or Linux server or desktop with 1+ Gb RAM and no pre-requisites. After installation, please follow our Getting Started Guide for step-by-step introduction to the application.
Read the product documentation including Windows and Linux installation instructions as well as Getting Started Guide: https://www.xtontech.com/resources/documentation/
Follow this link for the instructions how to update the existing setup: https://www.xtontech.com/resources/faq/updating-xton-access-manager-version/
Check the software pricing, including options and licensing FAQ: https://www.xtontech.com/store/
We appreciate your feedback and comments about Xton Access Manager and also about handling privileged accounts, passwords, keys and certificates as well as sessions to remote computers in general.
Thank you for your interest in our product.
Xton Technologies team
Xton Access Manager is an agentless cross-platform privileged account and access management solution with unlimited licensing model built from the ground up with an enterprise feature set yet simple, without your typical enterprise cost and effort.
Please fill out this form to receive a download link to get started today, even on your current desktop or laptop. Documentation is available to help or you can email or call us to request a trial extension, discuss questions and share your feedback. We would love to talk to you.